Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACAD
#1237
Acadia Pharmaceuticals Inc.
24.5
6
+1.24%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+1.24%
Mudança mensal
-6.83%
Mudança em 6 meses
-7.08%
Mudança anual
+28.05%
Fechamento anterior
24.2
6
Open
24.5
6
Bid
Ask
Low
24.5
6
High
24.5
6
Volume
140
Mercados
Ações
Cuidados de saúde
ACAD
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
160.05 M
161.2 M
162.23 M
164.77 M
166.79 M
170.49 M
—
Valuation ratios
Enterprise value
8.23 B
3.62 B
2.53 B
4.9 B
2.74 B
4.38 B
13.68 B
Price to earnings ratio
—
—
-12.18
-83.41
13.49
11.61
53.72
Price to sales ratio
—
—
0.01
0.01
3.19
—
—
Price to cash flow ratio
—
—
-0.02
0.3
19.36
41.32
97.09
Price to book ratio
—
—
0.01
0.01
4.17
3.7
7.12
Enterprise value to EBITDA ratio
-29.83
-22.27
-11.29
-61.66
7.43
—
—
Profitability ratios
Return on assets %
0.36
0.24
0.37
0.08
0.19
0.25
0.27
Return on equity %
0.45
0.31
0.54
0.14
0.31
0.32
0.36
Return on invested capital %
2 612.98
927.62
1 116.07
331.41
423.81
-90.92
6.7
Gross margin %
97.69
97.76
98.03
94.27
91.46
91.69
366.81
Operating margin %
64.87
35.2
43.23
10.1
24.1
9.78
39.09
EBITDA margin %
-62.46
-33.53
-43.37
-10.93
38.52
9.36
37.34
Net margin %
63.74
34.67
41.76
8.44
23.64
36.49
139.94
Liquidity ratios
Quick ratio
6.68
6.28
3.95
2.26
2.14
3.43
11.27
Current ratio
6.77
6.43
4.04
2.42
2.38
3.83
12.64
Inventory turnover
1.27
0.91
0.79
1.6
1.24
0.88
0.85
Asset turnover
0.56
0.65
0.8
1.09
0.99
0.78
0.85
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
0.71
0.1
0.95
0.65
0.65
EBIT per share
—
—
-1.38
-0.47
2.18
0.55
0.46
EBITDA per share
—
—
-1.39
-0.48
2.22
0.59
0.59
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
2.58
2.68
4.54
4.82
18.37
Net current asset value per share
—
—
3.14
3.76
5.64
6.25
23.45
Tangible book value per share
—
—
2.48
2.24
3.68
6.58
19.37
Working capital per share
—
—
2.36
2.21
3.27
4.62
15.97
Book value per share
—
—
2.48
2.64
4.4
7.22
22.04
ACADIA Pharmaceuticals Inc
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Notícias
ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth
Jefferies eleva preço-alvo das ações da Acadia Pharmaceuticals
Jefferies raises Acadia Pharmaceuticals stock price target on guidance
Citizens eleva preço-alvo da Acadia Pharmaceuticals com perspectiva de crescimento
Citizens raises Acadia Pharmaceuticals price target on growth outlook
ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ACAD) 2026-02-25
Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates
ACADIA Q4 2025 slides: $1B revenue milestone as both drugs post double-digit growth
Resultados da Acadia à vista: crescimento de Receita esperado apesar da queda nos lucros
Wolfe Research inicia cobertura de ações da Acadia com classificação outperform
Wolfe Research initiates Acadia stock with outperform rating